876062-69-0

Basic information

• Product Name: Glycine, N-[(1,1-dimethylethoxy)carbonyl]-, 5-(acetyloxy)-3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-6-yl ester
• CAS NO: 876062-69-0
• Molecular Formula: C24H29NO7
• Molecular Weight: 443.497
• Mol File: 876062-69-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Glycine, N-[(1,1-dimethylethoxy)carbonyl]-, 5-(acetyloxy)-3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-6-yl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Glycine, N-[(1,1-dimethylethoxy)carbonyl]-, 5-(acetyloxy)-3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-6-yl ester(876062-69-0)
• EPA Substance Registry System: Glycine, N-[(1,1-dimethylethoxy)carbonyl]-, 5-(acetyloxy)-3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-6-yl ester(876062-69-0)

Safety Data

• Hazardous Substances Data: 876062-69-0(Hazardous Substances Data)

Upstream product

• 4707-32-8 2,2-dimethyl-3,4-dihydro-2H-benzo[h]chromene-5,6-dione 
• 108-24-7 acetic anhydride 

Relevant articles and documents

Pharmaceutical compositions of beta-lapachone and beta-lapachone analogs with improved tumor targeting potential

The present invention relates to polymer-modified quinone-containing and carbonyl-containing therapeutic agents, including polymer-modified β-lapachone compounds, and methods of treating cancer by administering the polymer-modified therapeutic agents to a subject. Polymer-modification of therapeutic agents, such as β-lapachone compounds, provides effective transport of polymer-modified therapeutic agents to tumor cells or tumor tissues by exploiting the EPR effect in tumor tissues.